Session Details
[28-57-am]Clinical Pharmacy 18, Pharmacotherapies (Cancer)
Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 57 (C205, Bldg. 2, Area 2 [2F])
Discusser: Tappei Takada, Satohiro Masuda
[28-57-am-01S]Effects of Cold and Warm Compresses on Skin Injury in a Mouse Model of Oxaliplatin Extravasation
○Sumire Hirayama1, Risa Makisima1, Reiko Isii-Nozawa1, Tomiyuki Sugi1 (1. Meiji Pharmaceut. Univ.)
[28-57-am-02S]Effect of Shitei-To, a traditional Chinese medicine formulation, against hiccups~Effect of Shitei triterpenoids 4-aminopyridine-induced seizures in mice~
○Haruna Miyabe1, Yuki Tanaka1, Shinnosuke Komatsu1, Kazuki Aida1, Tomiyuki Sugi1, Reiko Isii-Nozawa1 (1. Meiji Pharmaceut. Univ.)
[28-57-am-03S]Effect of Shitei-To, a traditional Chinese medicine formulation, against hiccups~Effect of Shitei triterpenoids on pentylenetetrazole-induced convulsions in mice~
○Yuki Tanaka1, Haruna Miyabe1, Kouta Kurihara1, Kazuki Aida1, Tomiyuki Sugi1, Reiko Ishii-Nozawa1 (1. Meiji Pharmaceut. Univ.)
[28-57-am-04S]Inhibitory effect of Fasudil on oxaliplatin-induced peripheral neuropathy
○Saki Ichinohe1, Rin Kawanami1, Kazuki Aida1, Tomiyuki Sugi1, Reiko Ishii-Nozawa1 (1. Meiji Pharmaceut. Univ.)
[28-57-am-05S]A Survey on Current Adverse Event Reporting Practices in Tracing Reports for Outpatient Cancer Chemotherapy.
○Nao Yamagishi1, Yoko Ino1,2, Keiko Suzuki1,2, Tomohiro Osawa2, Kazuhide Tanaka1,2, Masahiro Yasuda1,2, Senji Kasahara1,3 (1. Gifu Pharm. Univ., 2. Dept. Pharm., Gifu Municipal Hosp., 3. Dept. Hematology, Gifu Municipal Hosp.)
[28-57-am-06S]Comprehensive Gene Expression Analysis in Mouse B16 Melanoma Cells During Tumor Progression Stages and the Involvement of Immune Evasion Mechanisms
○Yuri Hashimoto1, Kohei Kunimoto2, Kosuke Hashimoto3,6, Rin Hiraishi4, Miku Sugama1, Shoei Suzuki1, Akinori Taketani6, Akane Hara1, Kazutaka Akagi5,6, Koizumi Keiichi5,6 (1. Pharm. Sci., Univ. of Toyama, 2. Faculty of Med., Univ. of Toyama, 3. RIKEN, 4. Grad. Sch. of Med. and Pharm. Sci., Univ. of Toyama, 5. Insti. of Nat. Med., Univ. of Toyama, 6. Research Center for Pre-Disease Science., Univ. of Toyama)
[28-57-am-07S]Investigation of the safety of low-dose Cisplatin administration in combination with radiotherapy in patients with impaired renal function.
○Satoshi Tanaka1, Natsuki Mase1, Makoto Hanai2, Tomoya Abe2, Rina Sugiyama2, Toshiaki Nakayama2, Kimihiro Otsuka2, Tomiyuki Sugi1 (1. Meiji phamceut.Univ, 2. Saitama prefectural cancer center)
[28-57-am-08S]Impact of miR-29a-3p dynamics on platelet-to-lymphocyte ratio in lung cancer subtypes during pembrolizumab treatment
○Noa Hasegawa1, Kuninori Iwayama1, Mayuko Soma1, Yuka Yamagata2, Tatsuya Itoh2, Haruhiko Aisaka2, Maiko Machida1 (1. Hokkaido University of Science, 2. JCHO Sapporo Hokushin Hospital)
[28-57-am-09S]Impact of miR-155-5p dynamics on immune exhaustion resistance in lung cancer subtypes during pembrolizumab treatment
○Yuria Kitada1, Kuninori Iwayama1, Mayuko Soma1, Yuka Yamagata2, Tatsuya Itoh2, Haruhiko Aisaka2, Maiko Machida1 (1. Hokkaido University of Science, 2. JCHO Sapporo Hokushin Hospital)